IRCT20180620040164N43招募中Unknown
Comparative bioequivalence study of Alprazolam 0.5 mg Tablet of Karen Pharma and Food Supplement Co. and Xanax® of Pfizer as reference in 24 healthy male under fasting conditions
Karen Pharma and Food Supplement Co.0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 45 years(—)
- 性别
- Male
入选标准
- •Healthy subjects (male) between 20-45 years of age and Body Mass Index (BMI) within 15% of normal range values between 18.5-30 (inclusive), calculated as Kg/m2.
- •Subjects with no significant diseases or abnormal findings during laboratory evaluations and clinical examination.
- •Subjects with normal vital signs.
- •Subjects who agree with patient consent form.
排除标准
- •Subjects with known allergy to the products tested.
- •Subjects who have narrow angle glaucoma or are taking strong CYP3A inhibitors.
- •History of cardiovascular, kidney, hepatic, muscular, metabolic, gastrointestinal (including constipation), neurologic, endocrine, hematopoietic (any kind of anemia), asthma, mental or organic disease.
- •Subjects suffering from muscular trauma 21 days before the beginning of the study.
- •Consumption of caffeine-containing products from 24 hour before dosing through 24 hour after administration.
- •Any clinically significant illness during the 4 weeks prior to the first study drug administration.
- •Hypotension (systolic blood pressure =90 millimeter Hg (mmHg) or diastolic blood pressure =60 mmHg) or hypertension (systolic blood pressure =130mmHg or diastolic blood pressure =90 mmHg).
- •Smoking more than 10 cigarettes per day and could not tolerate cigarette cessation during each clinical period.
- •Recent use of concomitant medication (prescription or over-the-counter) that could increase the risk of bleeding, or influence alprazolam pharmacokinetics.
- •History of alcohol or drug abuse.
- •Heavy drinker of caffeine, grapefruit juice or caffeinated drinks or who are on special diet (such as vegetarians) or do exertional physical activity.
- •A history of difficulty with donating blood or donation of more than 500 ml blood within 7 days prior to the start of the study.
研究者
相似试验
已完成
2 期
Effect of alprazolam and clonazepam on blood glucose in adult panic patientspanic disorder.Panic disorder [episodic paroxysmal anxiety]IRCT2016040722991N3Vice Chancellor for research of Babol University of Medical Sciences45
已完成
1 期
Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets Under Fed ConditionsHealthyNCT00878514Orion Corporation, Orion Pharma18
已完成
不适用
Relative bioavailability comparison of Alprazolam 0.5mg tablet formulationsIRCT20201212049683N1Raha Pharmaceutical Company24
已完成
1 期
Bioequivalence Trial of Alprazolam 0.25 mg TabletsAnxiety DisordersNCT01853956GlaxoSmithKline28
招募中
2 期
The effect of two different tranquilizer drugs on anxiety in the patients candidate for surgeryIRCT20100102002963N33Yazd University of Medical Sciences66
